Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional health security architecture in ASEAN countries: Lessons from regional CDC models and Japan's strategic partnership for ACPHEED development.

Global health & medicine·2026
Same author

Mapping red blood cell phenotypes in Malaysia: A tool to overcome transfusion challenges for providing phenotype blood.

Asian journal of transfusion science·2025
Same author

"Idea-thon" to Promote Social Implementation of the SIP "Integrated Health Care System".

Studies in health technology and informatics·2025
Same author

Interventions to improve patient safety during the COVID-19 pandemic: a systematic review.

BMJ open quality·2025
Same author

The Japanese initiative for the Global Research Network and Link on Infectious Diseases (J-GRID+) Program and its prospects.

Global health & medicine·2025
Same author

The establishment of the Japan Institute for Health Security (JIHS): A new era in infectious disease response and research.

Global health & medicine·2025

Related Experiment Video

Updated: Jun 18, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Progress in global blood safety for HIV.

Teiji Takei1, Noryati Abu Amin, George Schmid

  • 1EMP/EVA/MOE, UNAIDS, Geneva, Switzerland. takeit@unaids.org

Journal of Acquired Immune Deficiency Syndromes (1999)
|November 11, 2009
PubMed
Summary

Global blood safety has improved, with 85% of countries reporting data. However, 34 countries still do not screen all donated blood for HIV, highlighting the need for universal quality-assured screening to prevent transfusion-transmitted infections.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Related Experiment Videos

Last Updated: Jun 18, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Blood Transfusion Safety

Background:

  • Ensuring a safe global blood supply is critical for public health.
  • Blood transfusion remains a potential route for HIV transmission.
  • Monitoring blood safety indicators is essential for global health initiatives.

Purpose of the Study:

  • To evaluate the progress made in establishing a safe global blood supply.
  • To assess the extent of HIV screening in donated blood worldwide.
  • To identify remaining gaps in blood safety practices.

Main Methods:

  • Utilized data from the United Nations General Assembly Special Session on HIV/AIDS (UNGASS) blood safety indicator.
  • Analyzed data from the World Health Organization's Global Database on Blood Safety (GDBS).
  • Reconciled and cross-checked data between UNGASS and GDBS by WHO and UNAIDS.

Main Results:

  • 147 UN Member States reported UNGASS data in 2008, with 125 (85%) submitting blood safety information.
  • 73% of reporting countries (91 out of 125) screened 100% of donated blood units with quality assurance.
  • Globally, 80.7 million blood units were collected (2004-2005), with 77.3 million tested for HIV, leaving 0.6 million untested.

Conclusions:

  • Significant progress has been achieved in reducing HIV transmission through blood transfusions.
  • Universal screening of all donated blood for HIV, adhering to quality standards, is crucial.
  • Achieving universal blood safety contributes to global health goals, including the Millennium Development Goals.